Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13.12.22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13.12.22 |
Amy M. McCord
LAW | General Counsel | - | 01.01.19 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13.12.22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02.08.13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23.08.23 |
Niraj Vasisht
BRD | Director/Board Member | 61 | 13.12.22 |
Michelle Yanez
BRD | Director/Board Member | 52 | 13.12.22 |
Michael Jerman
BRD | Director/Board Member | 40 | 24.05.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 172 023 545 | 71 400 692 ( 41,51 %) | 0 | 41,51 % |
Unternehmenskontakt
Inhibitor Therapeutics, Inc.
449 South 12th Street Unit 1705
33602, Tampa
+813 864 2562
http://www.inhibitortx.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+25,69 % | 47,86 Mrd. | |
+46,90 % | 41,42 Mrd. | |
-3,46 % | 40,66 Mrd. | |
-6,20 % | 28,92 Mrd. | |
+9,17 % | 25,55 Mrd. | |
-20,42 % | 19,27 Mrd. | |
+28,07 % | 12,14 Mrd. | |
+0,17 % | 12,15 Mrd. | |
-1,24 % | 11,99 Mrd. |